Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Testosterone lotion - Acrux

Drug Profile

Testosterone lotion - Acrux

Alternative Names: Axeron; Axiron; LY-900011; Testosterone MD-Lotion; Testosterone metered-dose lotion - Acrux

Latest Information Update: 05 Nov 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Acrux
  • Class Anabolic steroids; Androstenols; Erectile dysfunction therapies; Hormonal replacements; Small molecules; Testosterone congeners
  • Mechanism of Action Androgen receptor agonists; Testosterone replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Hypogonadism

Most Recent Events

  • 29 Jul 2019 Testosterone lotion is not yet available for Hypogonadism in Argentina, Austria, Finland, Norway, Sweden
  • 01 Apr 2015 Eli Lilly completes a phase III trial for Hypogonadism in USA, Argentina, Brazil, Germany, Italy, South Korea, Spain and the United Kingdom (NCT01816295; EudraCT 2012-004866-16)
  • 08 Jan 2015 Registered for Hypogonadism in Austria, Denmark, Finland, Norway and Sweden (Transdermal) through decentralised procedure (EMA website, April 2015)
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top